| Epigenetics of colorectal cancer: biomarker and therapeutic potential G Jung, E Hernández-Illán, L Moreira, F Balaguer, A Goel Nature reviews Gastroenterology & hepatology 17 (2), 111-130, 2020 | 671 | 2020 |
| Identification of Lynch syndrome among patients with colorectal cancer L Moreira, F Balaguer, N Lindor, A De la Chapelle, H Hampel, ... Jama 308 (15), 1555-1565, 2012 | 632 | 2012 |
| Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database M Dominguez-Valentin, JR Sampson, TT Seppälä, SW Ten Broeke, ... Genetics in Medicine 22 (1), 15-25, 2020 | 624 | 2020 |
| MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis K Hur, Y Toiyama, M Takahashi, F Balaguer, T Nagasaka, J Koike, ... Gut 62 (9), 1315-1326, 2013 | 624 | 2013 |
| Cancer chemoprevention by dietary polyphenols: promising role for epigenetics A Link, F Balaguer, A Goel Biochemical pharmacology 80 (12), 1771-1792, 2010 | 589 | 2010 |
| Fecal MicroRNAs as novel biomarkers for colon cancer screening A Link, F Balaguer, Y Shen, T Nagasaka, JJ Lozano, CR Boland, A Goel Cancer epidemiology, biomarkers & prevention 19 (7), 1766-1774, 2010 | 471 | 2010 |
| Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis F Balaguer, A Link, JJ Lozano, M Cuatrecasas, T Nagasaka, CR Boland, ... Cancer research 70 (16), 6609-6618, 2010 | 368 | 2010 |
| Risk of cancer in cases of suspected lynch syndrome without germline mutation M Rodríguez–Soler, L Pérez–Carbonell, C Guarinos, P Zapater, ... Gastroenterology 144 (5), 926-932. e1, 2013 | 263 | 2013 |
| The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status R Jover, P Zapater, A Castells, X Llor, M Andreu, J Cubiella, F Balaguer, ... European journal of cancer 45 (3), 365-373, 2009 | 249 | 2009 |
| Familial risk-colorectal cancer: ESMO clinical practice guidelines J Balmaña, F Balaguer, A Cervantes, D Arnold, ... Annals of oncology 24, vi73-vi80, 2013 | 244 | 2013 |
| A high degree of LINE-1 hypomethylation is a unique feature of early-onset colorectal cancer M Antelo, F Balaguer, J Shia, Y Shen, K Hur, L Moreira, M Cuatrecasas, ... Public Library of Science 7 (9), e45357, 2012 | 241 | 2012 |
| Endoscopic management of polyposis syndromes: European Society of Gastrointestinal Endoscopy (ESGE) guideline ME Van Leerdam, VH Roos, JE Van Hooft, E Dekker, R Jover, ... Endoscopy 51 (09), 877-895, 2019 | 240 | 2019 |
| 5-Fluorouracil adjuvant chemotherapy does not increase survival in patients with CpG island methylator phenotype colorectal cancer R Jover, TP Nguyen, L Pérez–Carbonell, P Zapater, A Payá, C Alenda, ... Gastroenterology 140 (4), 1174-1181, 2011 | 230 | 2011 |
| Hereditary gastrointestinal cancers: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up N Stjepanovic, L Moreira, F Carneiro, F Balaguer, A Cervantes, ... Annals of Oncology 30 (10), 1558-1571, 2019 | 227 | 2019 |
| Wireless capsule endoscopy in patients with obscure gastrointestinal bleeding: a comparative study with push enteroscopy A Mata, JM Bordas, F Feu, A Gines, M Pellise, G Fernández‐Esparrach, ... Alimentary pharmacology & therapeutics 20 (2), 189-194, 2004 | 220 | 2004 |
| Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer L Pérez-Carbonell, C Ruiz-Ponte, C Guarinos, C Alenda, A Payá, A Brea, ... Gut 61 (6), 865-872, 2012 | 219 | 2012 |
| The genetic basis of familial adenomatous polyposis and its implications for clinical practice and risk management ML Leoz, S Carballal, L Moreira, T Ocaña, F Balaguer The application of clinical genetics, 95-107, 2015 | 205 | 2015 |
| Curcumin modulates DNA methylation in colorectal cancer cells A Link, F Balaguer, Y Shen, JJ Lozano, HCE Leung, CR Boland, A Goel PloS one 8 (2), e57709, 2013 | 204 | 2013 |
| Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study F Balaguer, S Castellví–Bel, A Castells, M Andreu, J Muñoz, JP Gisbert, ... Clinical Gastroenterology and Hepatology 5 (3), 379-387, 2007 | 200 | 2007 |
| The clinical significance of MiR-148a as a predictive biomarker in patients with advanced colorectal cancer M Takahashi, M Cuatrecasas, F Balaguer, K Hur, Y Toiyama, A Castells, ... Public Library of Science 7 (10), e46684, 2012 | 178 | 2012 |
